Unveiling the Complexities of Hereditary Angioedema
Biomolecules · 2024
DOI: 10.3390/biom14101298 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Cristina Violeta Tutunaru und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. Hauptthemen laut MEDLINE: Angioedemas, Hereditary, Complement C1 Inhibitor Protein. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy of Craiova, Romania.
Abstract (Originalsprache)
Hereditary angioedema (HAE) is a rare and potentially life-threatening genetic disorder, constituting approximately 2% of all clinical cases of angioedema, with a global prevalence estimated between 1 in 50,000 and 1 in 150,000 individuals. The condition affects individuals of all genders and ethnic backgrounds without significant variation. HAE is classified into three types. Type I HAE, which accounts for 85% of cases, is characterized by a deficiency of the C1 esterase inhibitor (C1-INH) gene. Type II HAE, making up 15% of cases, involves a dysfunctional C1-INH. Type III HAE, which represents about 5% to 10% of cases, is often estrogen-dependent and although several mutations have been identified, it typically involves normal C1-INH activity. Despite the differences in C1-INH functionality, all three types of HAE manifest with similar clinical symptoms. HAE leads to recurrent episodes of non-pruritic angioedema, which occurs in the absence of urticaria. Breakthroughs in understanding HAE pathophysiology have revolutionized treatment, leading to the development of highly targeted therapies for both acute management and long-term prevention. Meanwhile, cutting-edge advancements in omics technologies are unlocking new possibilities for biomarker discovery, paving the way for more precise diagnoses and personalized treatment strategies that could significantly enhance patient outcomes. This review will delve into the intricate pathophysiology, diverse clinical presentations, and diagnostic challenges of HAE while exploring emerging biomarkers and innovative approaches to therapeutic management and prevention strategies. Additionally, it will underscore the vital importance of screening family members of affected individuals, even when symptoms are not present.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Urology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Department of Oncologic Dermatology, "Elias" Emergency University Hospital, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Clinic of Dermatology, "Elias" Emergency University Hospital, 011461 Bucharest, Romania.
ORCID-Profile: Olguța Anca Orzan, Beatrice Bălăceanu-Gurău
Förderung
- University of Medicine and Pharmacy of Craiova, Romania
Zitieren
APA
Tutunaru, C. V., Ică, O. M., Mitroi, G. G., Neagoe, C. D., Mitroi, G. F., Orzan, O. A., Bălăceanu-Gurău, B., & Ianoși, S. L. (2024). Unveiling the Complexities of Hereditary Angioedema. Biomolecules. https://doi.org/10.3390/biom14101298
Vancouver
Tutunaru CV, Ică OM, Mitroi GG, Neagoe CD, Mitroi GF, Orzan OA, et al. Unveiling the Complexities of Hereditary Angioedema. Biomolecules. 2024. doi:10.3390/biom14101298
BibTeX
@article{Tutunaru2024,
author = {Tutunaru, Cristina Violeta and Ică, Oana Maria and Mitroi, George G and Neagoe, Carmen Daniela and Mitroi, George F and Orzan, Olguța Anca and Bălăceanu-Gurău, Beatrice and Ianoși, Simona Laura},
title = {Unveiling the Complexities of Hereditary Angioedema},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14101298}
}
EUVIMED